Submit Deal

Announced

9 Sep 2025

Completed

9 Sep 2025

Arcadia Investment Partners-backed Cristae Therapeutics completed the acquisition of a novel bile-acid therapeutics business from Advent International for $25m.

Synopsis

Arcadia Investment Partners-backed Cristae Therapeutics, a UK-based, privately held company, completed the acquisition of a novel bile-acid therapeutics business from Advent International, a private equity firm, for $25m.

Principals

target

Advent International (novel Bile-acid Therapeutics Business)

bidder

Cristae Therapeutics

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

Sort

Vendor Team (12)

thomas samuel

Associate at CMS Legal

Lawyer

vendor

Deal

£ 18 M

Total Value

tom allen

Managing Director at ADVENT INTERNATIONAL CORPORATION

Investor

vendor

Deals

£ 2.05 B

Total Value

robbie somerville

Partner at CMS Legal

Lawyer

vendor

Deals

£ 314 M

Total Value

kieran sargent

Associate at CMS Legal

Lawyer

vendor

Deals

£ 2.09 B

Total Value

melissa laurie mcclean

Associate at CMS Legal

Lawyer

vendor

Deal

£ 18 M

Total Value

anya fitzpatrick

Associate at CMS Legal

Lawyer

vendor

Deal

£ 18 M

Total Value

aaron fairhurst

Partner at CMS Legal

Lawyer

vendor

Deals

£ 3.37 B

Total Value

kieran macarthur

Associate at CMS Legal

Lawyer

vendor

Deals

£ 18 M

Total Value

haris saleem

Associate at CMS Legal

Lawyer

vendor

Deal

£ 18 M

Total Value

andrew boden

Assistant Company Secretary at CMS Legal

Lawyer

vendor

Deal

£ 18 M

Total Value

amelia goodair

Associate at CMS Legal

Lawyer

vendor

Deals

£ 18 M

Total Value

amy mckeown

Trainee Solicitor at CMS Legal

Lawyer

vendor

Deal

£ 18 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy